Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended				35 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2023
Cash flows from operating activities
Net income/(loss)	$ (327,599,700)	$ (9,177,900)	$ (22,768,100)	$ (210,300)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense on debt	2,817,600			2,024,300
Change in fair value of derivative liability	225,916,000			(5,659,900)
Depreciation	5,600			16,500
Loss on extinguishment of debt	542,300			0
Stock based compensation	84,588,000			0
Non-cash charge for operating lease	400			1,800
Prepaid expenses and other current assets	2,800			0
Accounts Receivable	33,800			13,200
Unearned Revenue	(695,900)			0
Accounts payable	5,073,100			39,900
Net cash used in operating activities	(9,316,000)			(3,774,500)	$ (12,577,300)
Cash flows used in investing activities
Purchases of property and equipment	0			0
Net cash used in investing activities	0			0
Cash flows provided by financing activities
Proceeds from convertible promissory notes	47,455,000			0
Proceeds from merger	233,017,500			0
Net cash provided by financing activities	280,472,500			0
Net change in cash and cash equivalents and restricted cash	271,156,500			(3,774,500)
Cash and cash equivalents and restricted cash, beginning of period	2,572,700		$ 6,033,900	9,808,400
Cash and cash equivalents and restricted cash, end of period	273,729,200	2,572,700		6,033,900	2,572,700
Reconciliation of cash and cash equivalents and restricted cash to the condensed consolidated balance sheets
Cash and cash equivalents	233,700,900	2,572,700		6,033,900	2,572,700
Restricted cash	40,028,300	$ 0		0	$ 0
Supplemental disclosure of cash flow information
Cash paid for interest	0			0
Cash paid for taxes	0			0
Non cash investing and financing activities
Shares issued for conversion of convertible notes	$ 300,426,000			$ 0